共 19 条
[11]
Tan E.M., Cohen A.S., Fries J.F., Et al., revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, pp. 1271-1982, (1982)
[12]
Miller M.H., Littlejohn G.O., Davidson A., Jones B., Topliss D.J., The clinical significance of the anticentromere antibody, Br J Rheumatol, 26, pp. 17-1987
[13]
Powell F.C., Schroeter A.L., Dickson E.R., Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases, Q J Med, 62, (1987)
[14]
Clup K.S., Autoimmune association of primary biliary cirrhosis, Mayo Clin Proc, 57, (1982)
[15]
Bernstein R.M., Callender M.E., Neuberger J.M., Hughes G.R.V., Williams R., Anticentromere antibody in primary biliary cirrhosis, Ann Rheum Dis, 41, (1982)
[16]
Reynolds T., Denison E., Frankl H., Lieberman F., Peters R., Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasis, Am J Med, 50, (1971)
[17]
Cassani F., Bianchi F.B.B., Lenzi M., Volta U., Pisi E., Immunomorphological characterisation of antinuclear antibodies in chronic liver disease, J Clin Pathol, 38, (1985)
[18]
Makinen D., Fritzler M., Davis P., Sherlock S., Anticentromere antibodies in primary biliary cirrhosis, Arthritis Rheum, 26, (1983)
[19]
Weiner E., Hildebrandt S., Senecal J., Et al., Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease, Arthritis Rheum, 34, (1991)